section name header

Information

Editors

PiaHalonen
EijaHiltunen-Back

Pelvic Inflammatory Disease (Pid)

Essentials

  • Pelvic inflammatory disease (PID) is an acute infection usually originating in the uterine cervix, which may cause endometritis, salpingitis, oophoritis, pelvic abscess, peritonitis and/or perihepatitis.
  • Early diagnosis and treatment prevent late sequelae of PID:
    • infertility due to fallopian tube damage
    • ectopic pregnancy
    • chronic abdominal pain.

Epidemiology

  • PID mainly occurs in sexually active women of reproductive age. The risk of PID is highest in the youngest age groups.
    • If the clinical picture in a postmenopausal patient resembles PID, careful differential diagnosis is required (high risk of malignancy).
  • In 2019, the global age-standardized prevalence rate (ASPR) of PID was 53.19 per 100 000. For details, see http://pmc.ncbi.nlm.nih.gov/articles/PMC10544469/.

Aetiology

  • Usually a mixed infection, and the causative pathogens cannot necessarily be detected by microbiological methods.
    • Chlamydia trachomatisChlamydia and Neisseria gonorrhoeae Gonorrhoea often cause PID in women of reproductive age. An estimated 10-15% of cervical chlamydial or gonococcal infections proceed to PID.
    • Mycoplasma genitalium is another probable cause of PID in premenopausal patients.
    • Anaerobic bacteria in the vaginal microbiome may also be associated with PID.
    • Intestinal or respiratory tract bacteria are involved more rarely.
  • Inserting an IUD will increase the risk of PID for a few weeks.

Clinical picture

  • The possibility of PID must be kept in mind if a patient of reproductive age presents with lower abdominal pain and abnormal vaginal discharge. The clinical diagnosis can be made based on typical symptoms and findings and basic investigations.
  • The clinical picture varies from nearly asymptomatic to life-threatening.
  • Symptoms
    • Bilateral lower abdominal pain
      • Pain on intercourse, pain on urination
    • Abnormal vaginal discharge
      • Intermenstrual bleeding, postcoital bleeding, purulent discharge
    • Low-grade fever / fever
  • Findings
    • Palpation of the abdomen: tenderness of the lower abdomen
    • Pelvic examination: cervical, uterine and adnexal tenderness
    • Speculum examination: purulent or bloody cervical discharge

Workup

Basic investigations in outpatient care

  • Basic blood count with platelet count, CRP (severe PID: leucocytosis and elevated CRP)
  • Nucleic acid detection test for Chlamydia trachomatis and Neisseria gonorrhoeae (cervical or vaginal sample)
  • Differential diagnosis
    • Chemical screening of urine, bacterial culture of urine
    • Total plasma hcG
    • Nucleic acid detection test for Mycoplasma genitalium, as necessary (cervical or vaginal sample)

Further investigations in specialized care

  • Transvaginal ultrasonography
    • PID findings are often limited and open to interpretation.
    • Findings clearly suggestive of PID: pyosalpinx, abscess
  • Vaginal smear
    • Absence of leucocytosis has good negative predictive value.
  • Rarely endometrial biopsy
  • MRI or CT mainly for differential diagnosis
  • Laparoscopy mostly in PID refractory to conservative treatment

Differential diagnosis

Treatment

  • To avoid consequences affecting fertility, PID should be diagnosed and treatment started without hesitation in patients of reproductive age.
  • Treatment should be chosen to cover the most important potential causative bacteria and also a mixed infection; treatment should be directed at chlamydia, gonorrhoea and anaerobic bacteria.
  • Outpatient management if:
    • the patient's general condition is good
    • inflammatory markers are only slightly increased.
  • Antimicrobial treatment in outpatient care
    • Doxycycline 100 mg twice daily for 14 days and metronidazole 400 mg three times daily for 14 days
    • If gonorrhoea is diagnosed
      • a single dose of ceftriaxone 1 g i.m. should be added to the regimen, and
      • a gonococcal culture sample should preferably be taken for antimicrobial susceptibility testing before starting the treatment (see Gonorrhoea).
    • If gonorrhoea or chlamydia is diagnosed, ensure contact tracing (see Chlamydia).
    • If chlamydial and gonococcal infections can be excluded and the infection occurs after the insertion of an IUD, for example, it is usually a mixed infection caused by normal vaginal flora.
      • This can be treated with a combination of cephalexin (500 mg three times daily or 750 mg twice daily) and metronidazole (500 mg twice daily or 400 mg three times daily).
  • Indications for hospital treatment
    • Severe symptoms: high fever, poor general condition
    • Complicated PID: suspected abscess in the lesser pelvis
    • PID refractory to outpatient care
    • Uncertain diagnosis, differential diagnostic problems
    • Pregnant women
  • Antimicrobial treatment in hospital
    • Ceftriaxone 2 g i.v. once daily, doxycycline 100 mg i.v. or p.o. twice daily, metronidazole 400 mg i.v. or p.o. three times daily
    • After the patient's clinical condition improves, intravenous antimicrobial treatment should be continued for another day. It can then be replaced by oral medication.
      • Doxycycline 100 mg twice daily and metronidazole 400 mg three times daily to make the total duration of treatment 14 days
  • Symptomatic treatment: NSAID, rest, sick leave
  • If a patient with PID has an IUD, it should be removed if PID is refractory to antimicrobial treatment.
    • Remember to arrange postcoital contraception and further contraception, as necessary.
  • If PID was due to chlamydia or gonorrhoea, a control sample (nucleic acid detection test for chlamydia and gonorrhoea) should be taken 4 weeks after the end of treatment.
  • The sexual partner(s) should be examined: samples for chlamydia and gonorrhoea tests.

Prognosis

  • PID should be readily treated to prevent any late complications.
  • PID may damage the fallopian tubes, leading to subfertility.
    • A single case of PID with treatment begun at an early stage will hardly affect fertility.
    • The risk of infertility is increased if the patient has had severe PID or several episodes of PID.
  • PID may increase the risk of ectopic pregnancy to some extent.
  • About 30% of patients develop chronic pelvic pain.

    References

    • Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2018;29(2):108-114 [PubMed]